Malin Corporation plc (ISE:MLC)
Ireland · Delayed Price · Currency is EUR 7.70
+0.10 (1.32%)
Mar 20, 2026, 4:30 PM GMT
Malin Corporation Company Description
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America.
It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases.
The company was incorporated in 2014 and is headquartered in Dublin, Ireland.
Malin Corporation plc
| Country | Ireland |
| Founded | 2014 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Fiona Dunlevy |
Contact Details
Address: The Lennox Building Dublin, D02 FK02 Ireland | |
| Phone | 353 1 905 3531 |
| Website | malinplc.com |
Stock Details
| Ticker Symbol | MLC |
| Exchange | Euronext Dublin |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | IE00BVGC3741 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Fiona Dunlevy | Chief Executive Officer, Company Secretary and Executive Director |
| William F. Daniel | Non-Executive Chair |
| Andrea Stafford | Head of Finance |